TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11018567

Group type: EXPERIMENTAL
Intervention: Standard dose dialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High dose dialysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low flux membranes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High flux membranes
Number of subjects: 0
Study: 9075752

Group type: EXPERIMENTAL
Intervention: Guided imagery intervention (listened to a guided imagery tape three days preoperatively; a music‐only tape during induction, during surgery, and postoperatively in the recovery room; a guided imagery tape during each of the first six postoperative days)
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Guided imagery intervention
Number of subjects: 2

Group type: COMPARATOR
Intervention: Standard perioperative care (Control group)
Number of subjects: 2
Study: 8396374

Group type: EXPERIMENTAL
Intervention: Piperacillin/Tazobactam
Number of subjects: 331

Group type: COMPARATOR
Intervention: Clindamycin and Gentamicin
Number of subjects: 331
Study: 3463575

Group type: EXPERIMENTAL
Intervention: Manual V‐shaped toothbrush
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Manual multitufted toothbrush
Number of subjects: 22

Group type: COMPARATOR
Intervention: Electric toothbrush
Number of subjects: 22
Study: 29158449

Group type: EXPERIMENTAL
Intervention: Induced hypertension
Number of subjects: 41

Group type: COMPARATOR
Intervention: No induced hypertension
Number of subjects: 41
Study: 26476151

Group type: EXPERIMENTAL
Intervention: 4-valent HPV vaccine
Number of subjects: 332

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 332
Study: 24419017

Group type: EXPERIMENTAL
Intervention: Electrical stimulation to supraspinatus, posterior deltoid & long head of biceps along with routine physiotherapy and occupational therapy for 5 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Electrical stimulation to supraspinatus & posterior deltoid along with routine physiotherapy and occupational therapy for 5 weeks
Number of subjects: 24
Study: 22284923

Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin A 10,000 IU 3 times weekly from day 2 for a minimum of 2 weeks or until establishment of oral feeding
Number of subjects: 89

Group type: COMPARATOR
Intervention: Control group (no vitamin A supplementation)
Number of subjects: 89
Study: 20390502

Group type: EXPERIMENTAL
Intervention: Provider-initiated ('opt-out') HIV counseling
Number of subjects: 0
Study: 18413705

Group type: EXPERIMENTAL
Intervention: CP-316,311 (400 mg twice daily)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Sertraline (100 mg daily)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study: 15312100

Group type: EXPERIMENTAL
Intervention: GTR/bone replacement material
Number of subjects: 124

Group type: COMPARATOR
Intervention: Access flap alone
Number of subjects: 124
Study: 10911771

Group type: EXPERIMENTAL
Intervention: Efacal (Ca 1.0 g, evening primrose oil 4.0 g, marine fish oil 440 mg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Calcium alone (Ca 1.0 g)
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Efacal
Number of subjects: 85

Group type: COMPARATOR
Intervention: Calcium alone
Number of subjects: 85
Study: 9192063

Group type: EXPERIMENTAL
Intervention: Aminosalicylates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Corticosteroids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Budesonide (new topical steroid)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Short-chain fatty acids, local anaesthetics, bismuth compounds
Number of subjects: 0
Study: 7506185

Group type: EXPERIMENTAL
Intervention: Aspirin (acetylsalicylic acid)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Imidazole-hydroxybenzoate
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Nimesulide
Number of subjects: 112
Study: 3723448

Group type: EXPERIMENTAL
Intervention: Anxiety-inducing cognitive task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Velten-type depression-inducing manipulation
Number of subjects: 0
Study: 31485722

Group type: EXPERIMENTAL
Intervention: Deep-brain stimulation (DBS) with non-rechargeable batteries
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Deep-brain stimulation (DBS) with rechargeable batteries
Number of subjects: 17

Group type: COMPARATOR
Intervention: Best medical treatment (BMT)
Number of subjects: 17
Study: 27888561

Group type: EXPERIMENTAL
Intervention: Basal insulin peglispro (BIL)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Insulin glargine (GL)
Number of subjects: 52
Study: 27054797

Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD) using BladderTrakHer Web app
Number of subjects: 122

Group type: COMPARATOR
Intervention: Paper voiding diary (PVD)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD)
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Electronic voiding diary (EVD) and Paper voiding diary (PVD)
Number of subjects: 122
Study: 24378283

Group type: EXPERIMENTAL
Intervention: PEG-IFN + RBV
Number of subjects: 176
Study: 22449810

Group type: EXPERIMENTAL
Intervention: Glass-ionomer cement (GIC)
Number of subjects: 173

Group type: EXPERIMENTAL
Intervention: Resin-based fissure sealant
Number of subjects: 173
Study: 19540640

Group type: EXPERIMENTAL
Intervention: Atorvastatin, 10 mg/d
Number of subjects: 2838
Study: 17560731

Group type: EXPERIMENTAL
Intervention: Trained men (elite sportsmen)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Untrained men
Number of subjects: 44
Study: 15446651

Group type: EXPERIMENTAL
Intervention: Visual analogue scale (VAS) ratings for musculoskeletal fatigue after applying external loads at 0, 5, 10, 15, 25, 35, and 50% of maximum voluntary contraction.
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Higher external loads (25‐50% maximum load)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Lower external loads (0‐15% maximum load)
Number of subjects: 20
Study: 10858380

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 208

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 208
Study: 9040258

Group type: EXPERIMENTAL
Intervention: Ambulatory care curriculum (3-week component including evaluation of walk-in patients, exposure to community internists, and a lecture series)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Traditional curriculum (exclusively inpatient)
Number of subjects: 196
Study: 8457023

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (100 micrograms sodium selenite daily for 14 weeks)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3510704

Group type: EXPERIMENTAL
Intervention: Mechanical stapling with a GIA/TA instrument (43 patients)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional two-layer hand suturing (45 patients)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Mechanical stapling (43 patients)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Conventional suturing (45 patients)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 88
Study: 31082538

Group type: EXPERIMENTAL
Intervention: Surgical ablation (SA)
Number of subjects: 207

Group type: COMPARATOR
Intervention: Control (no ablation)
Number of subjects: 207
Study: 29737274

Group type: EXPERIMENTAL
Intervention: Therapeutic drug monitoring
Number of subjects: 263

Group type: COMPARATOR
Intervention: Clinical features monitoring
Number of subjects: 263
Study: 27157953

Group type: EXPERIMENTAL
Intervention: Gum chewing (three times a day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no gum chewing)
Number of subjects: 60
Study: 26276914

Group type: EXPERIMENTAL
Intervention: Presence of depression during 6 months after myocardial infarction
Number of subjects: 44

Group type: COMPARATOR
Intervention: No depression during 6 months after myocardial infarction
Number of subjects: 44
Study: 24108261

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Flumazenil
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 21368663

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type B (BT)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Trimacinolone injection (TA)
Number of subjects: 61
Study: 18199130

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day for 4 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Sildenafil 25 mg three times a day for 4 days followed by placebo for 3 weeks
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chronic sildenafil administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 16618044

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control procedures (minimal, superficial, sham acupuncture)
Number of subjects: 0
Study: 14662284

Group type: EXPERIMENTAL
Intervention: Vitamin-mineral supplement containing recommended daily allowance (RDA) dosages
Number of subjects: 0

Group type: COMPARATOR
Intervention: No supplementation
Number of subjects: 0
Study: 11894282

Group type: EXPERIMENTAL
Intervention: Metamucil
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no Metamucil)
Number of subjects: 60
Study: 8922504

Group type: EXPERIMENTAL
Intervention: Geristore (resin modified glass ionomer cement)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phase II (composite resin)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Geristore
Number of subjects: 40

Group type: COMPARATOR
Intervention: Phase II
Number of subjects: 40
Study: 1395760

Group type: EXPERIMENTAL
Intervention: Flosequinan
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 30888691

Group type: EXPERIMENTAL
Intervention: Imidafenacin 0.2 mg
Number of subjects: 300

Group type: COMPARATOR
Intervention: Tolterodine 4 mg
Number of subjects: 300
Study: 28257107

Group type: EXPERIMENTAL
Intervention: Micronutrient-fortified milk
Number of subjects: 296

Group type: COMPARATOR
Intervention: Unfortified milk
Number of subjects: 296
Study: 26108207

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home program (2-week telephone outreach initiative)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Further Enabling Care at Home program
Number of subjects: 180
Study: 24314835

Group type: EXPERIMENTAL
Intervention: Hemianopia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Quadrantanopia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Central scotoma
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Reliability measures
Number of subjects: 30
Study: 22524831

Group type: COMPARATOR
Intervention: HPV16 single infection
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: HPV16 multiple infection
Number of subjects: 8
Study: 19651872

Group type: EXPERIMENTAL
Intervention: RTS,S/AS02D malaria vaccine candidate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparator vaccine
Number of subjects: 0
Study: 18804274

Group type: EXPERIMENTAL
Intervention: Erythromycin
Number of subjects: 3298
Study: 15319311

Group type: EXPERIMENTAL
Intervention: Imitation tasks using photographs of hand postures or symbolic specification of the postures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Delayed execution tasks
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Functional magnetic resonance imaging (fMRI)
Number of subjects: 0
Study: 12241657

Group type: EXPERIMENTAL
Intervention: 600 mg rifapentine plus 900 mg isoniazid once a week
Number of subjects: 1004

Group type: COMPARATOR
Intervention: 600 mg rifampicin plus 900 mg isoniazid twice a week
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: 600 mg rifapentine plus 900 mg isoniazid once a week (without cavitation)
Number of subjects: 1004

Group type: COMPARATOR
Intervention: 600 mg rifampicin plus 900 mg isoniazid twice a week (without cavitation)
Number of subjects: 1004

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 1004
Study: 9973585

Group type: EXPERIMENTAL
Intervention: Self-massage treatment
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study: 7549378

Group type: EXPERIMENTAL
Intervention: Red Ginseng
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Red Ginseng plus digoxin
Number of subjects: 45

Group type: COMPARATOR
Intervention: digoxin
Number of subjects: 45
Study: 2142731

Group type: EXPERIMENTAL
Intervention: Naprosyn 500 mg b.i.d. for 30 days
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 6254602

Group type: EXPERIMENTAL
Intervention: Ispaghula, Motival, and Mebeverine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Mebeverine with Motival
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Mebeverine with Lorazepam
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Ispaghula
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bran, Motival, and Hyoscine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Bran, Lorazepam, and Mebeverine
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Combination of agents
Number of subjects: 96
Study: 30848098

Group type: EXPERIMENTAL
Intervention: Mid-fantasy cartoons
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: High-fantasy cartoons
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Low-fantasy cartoons
Number of subjects: 143

Group type: EXPERIMENTAL
Intervention: Working memory tasks
Number of subjects: 143
Study: 25172884

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (Mindful Family Stress Reduction)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 41
Study: 25871017

Group type: EXPERIMENTAL
Intervention: Sesame seed supplementation (40 g daily for 2 months)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (40 g placebo powder daily for 2 months)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both groups (Sesame and Control)
Number of subjects: 50
Study: 23866689

Group type: EXPERIMENTAL
Intervention: Skin prick tests for allergens
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Grass mix
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Olea European
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Dust mites mix
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Cypress
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Parietaria officinalis
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Cat dander
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Dog dander
Number of subjects: 497

Group type: EXPERIMENTAL
Intervention: Altenaria
Number of subjects: 497
Study: 21142752

Group type: EXPERIMENTAL
Intervention: Physical activity intervention
Number of subjects: 20
Study: 19480651

Group type: EXPERIMENTAL
Intervention: Continuous theta-burst stimulation (cTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intermittent theta-burst stimulation (iTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Intermediate theta-burst stimulation (imTBS) over left inferior temporal cortex, 600 pulses at 80% of individual active or resting motor threshold
Number of subjects: 20

Group type: COMPARATOR
Intervention: Responder group
Number of subjects: 20

Group type: COMPARATOR
Intervention: Non-responder group
Number of subjects: 20
Study: 17363193

Group type: EXPERIMENTAL
Intervention: Injecting alone (n=467)
Number of subjects: 3199

Group type: COMPARATOR
Intervention: Other IDUs (control group)
Number of subjects: 3199
Study: 14707555

Group type: EXPERIMENTAL
Intervention: 546C88
Number of subjects: 312

Group type: COMPARATOR
Intervention: Placebo (5% dextrose)
Number of subjects: 312
Study: 11351929

Group type: COMPARATOR
Intervention: Procyclidine 10 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Procyclidine 15 mg
Number of subjects: 2

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study: 8996134

Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Clodronate 1,500 mg
Number of subjects: 32
Study: 8942149

Group type: EXPERIMENTAL
Intervention: ofloxacin 400 mg daily (BB)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: ofloxacin 800 mg daily (CC)
Number of subjects: 26

Group type: COMPARATOR
Intervention: clofazimine 50 mg daily and 300 mg once in 4 weeks + dapsone 100 mg daily (AA)
Number of subjects: 26
Study: 3605734

Group type: EXPERIMENTAL
Intervention: Nitrous oxide (60% nitrous oxide in oxygen with 1.4% isoflurane)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Control (1.4% isoflurane in oxygen)
Number of subjects: 98
Study: 29750266

Group type: EXPERIMENTAL
Intervention: Hyperuricemia (HUA) group
Number of subjects: 460

Group type: COMPARATOR
Intervention: Normouricemic group
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: HUA group (men)
Number of subjects: 460

Group type: EXPERIMENTAL
Intervention: HUA group (women)
Number of subjects: 460
Study: 26852238

Group type: EXPERIMENTAL
Intervention: OverMDC (mean distance to conformity) with a prescribed dose of 50Gy
Number of subjects: 97

Group type: COMPARATOR
Intervention: 3D-CRT
Number of subjects: 97

Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Re-planning from 3D-CRT to VMAT
Number of subjects: 97
Study: 25607338

Group type: EXPERIMENTAL
Intervention: 30 mg/d pioglitazone
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1,000 mg/d metformin
Number of subjects: 84
Study: 24135734

Group type: EXPERIMENTAL
Intervention: 3 MV combined with PrEP (tenofovir/emtricitabine)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 MV combined with placebo
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: 3 MV alone
Number of subjects: 68
Study: 20569733

Group type: EXPERIMENTAL
Intervention: Intracoronary infusion of autologous bone marrow mononuclear cells (BMMC)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Intravascular ultrasound substudy
Number of subjects: 37
Study: 19077833

Group type: EXPERIMENTAL
Intervention: Optimal Soothing Environment (OSE)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 50
Study: 16608559

Group type: EXPERIMENTAL
Intervention: Body-oriented psychological therapy (BPT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Supportive counseling (SC)
Number of subjects: 45
Study: 11918829

Group type: EXPERIMENTAL
Intervention: 1000 mg acetaminophen (paracetamol) 6 times daily for 5 days
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: 400 mg ibuprofen 6 times daily for 5 days
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo 6 times daily for 5 days
Number of subjects: 75
Study: 10593430

Group type: EXPERIMENTAL
Intervention: Dalteparin once daily (mean 4631 IU anti-factor Xa units/day)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Unfractionated heparin twice daily (mean 20569 IU/day)
Number of subjects: 105
Study: 8943981

Group type: EXPERIMENTAL
Intervention: Short-chain fatty acid mixture
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Butyrate alone
Number of subjects: 47

Group type: COMPARATOR
Intervention: Saline placebo
Number of subjects: 47
Study: 1755884

Group type: EXPERIMENTAL
Intervention: 10 ml 0.5% bupivacaine with adrenaline
Number of subjects: 40

Group type: COMPARATOR
Intervention: 10 ml placebo
Number of subjects: 40
Study: 6612389

Group type: EXPERIMENTAL
Intervention: 100 mg intravenous lidocaine
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: 160 mg topical lidocaine
Number of subjects: 16
Study: 29241943

Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 2973

Group type: COMPARATOR
Intervention: Women
Number of subjects: 2973
Study: 27406242

Group type: EXPERIMENTAL
Intervention: TIME intervention (multicomponent program including rigorous assessment, case conferences, treatment and evaluation of NPS)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Brief education-only intervention regarding dementia and NPS (control group)
Number of subjects: 168
Study: 24733235

Group type: EXPERIMENTAL
Intervention: Varenicline (VAR; 1 mg twice daily) + Low dose naltrexone (L-NTX; 25 mg once daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Varenicline (VAR; 1 mg twice daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Low dose naltrexone (L-NTX; 25 mg once daily)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study: 23113779

Group type: EXPERIMENTAL
Intervention: WCP (Weight Concerns Program)
Number of subjects: 2000

Group type: COMPARATOR
Intervention: STD (Standard Quitline)
Number of subjects: 2000
Study: 19735607

Group type: EXPERIMENTAL
Intervention: SMS text messages prompting
Number of subjects: 62

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 62
Study: 18578967

Group type: EXPERIMENTAL
Intervention: TNF inhibitors
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of TNF inhibitors and methotrexate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Methotrexate
Number of subjects: 0
Study: 15914522

Group type: EXPERIMENTAL
Intervention: Insulin treatment
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control (healthy nondiabetic children)
Number of subjects: 19
Study: 12872395

Group type: EXPERIMENTAL
Intervention: Chinese herbal medicine (TCM) for activating blood circulation to remove stasis, treated for 3 months
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional treatment, treated for 3 months
Number of subjects: 49
Study: 11012950

Group type: COMPARATOR
Intervention: Conventional verbal information from an ENT nurse
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Specific information including role-play from a nurse anaesthetist
Number of subjects: 160
Study: 8774016

Group type: EXPERIMENTAL
Intervention: Visual stimulation (viewing high-action videotape of human stunts)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Visual stimulation
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Auditory stimulation (listening to fast upbeat music)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Auditory/visual stimulation (both stimulations)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no stimulation)
Number of subjects: 24
Study: 1729934

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) stimulation at 10 mA above T4 threshold
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Train-of-four (TOF) stimulation at various currents (10, 15, 20, 30, 40, 50, and 60 mA)
Number of subjects: 31